These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2451570)

  • 1. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Bitar DM; Whitacre CC
    Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
    Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
    Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
    Miller A; Lider O; Abramsky O; Weiner HL
    Eur J Immunol; 1994 May; 24(5):1026-32. PubMed ID: 7514126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
    Miller A; Lider O; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
    Pope L; Paterson PY; Miller SD
    J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
    al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
    Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
    J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
    Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
    J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
    Popovich PG; Yu JY; Whitacre CC
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Khoury SJ; Lider O; al-Sabbagh A; Weiner HL
    Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
    Jewell SD; Gienapp IE; Cox KL; Whitacre CC
    Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-driven bystander suppression after oral administration of antigens.
    Miller A; Lider O; Weiner HL
    J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates.
    McKenna RM; Carter BG; Paterson JA; Sehon AH
    Cell Immunol; 1983 Oct; 81(2):391-402. PubMed ID: 6196127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
    Higgins PJ; Weiner HL
    J Immunol; 1988 Jan; 140(2):440-5. PubMed ID: 2447178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.